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ABSTRACT Brucella species are Gram-negative bacteria that infect mammals. Recently, two unusual strains (Brucella inopinata
BO1T and B. inopinata-like BO2) have been isolated from human patients, and their similarity to some atypical brucellae iso-
lated from Australian native rodent species was noted. Here we present a phylogenomic analysis of the draft genome sequences
of BO1T and BO2 and of the Australian rodent strains 83-13 and NF2653 that shows that they form two groups well separated
from the other sequenced Brucella spp. Several important differences were noted. Both BO1T and BO2 did not agglutinate signif-
icantly when live or inactivated cells were exposed to monospecific A and M antisera against O-side chain sugars composed of
N-formyl-perosamine. While BO1T maintained the genes required to synthesize a typical Brucella O-antigen, BO2 lacked many
of these genes but still produced a smooth LPS (lipopolysaccharide). Most missing genes were found in the wbk region involved
in O-antigen synthesis in classic smooth Brucella spp. In their place, BO2 carries four genes that other bacteria use for making a
rhamnose-based O-antigen. Electrophoretic, immunoblot, and chemical analyses showed that BO2 carries an antigenically dif-
ferent O-antigen made of repeating hexose-rich oligosaccharide units that made the LPS water-soluble, which contrasts with the
homopolymeric O-antigen of other smooth brucellae that have a phenol-soluble LPS. The results demonstrate the existence of a
group of early-diverging brucellae with traits that depart significantly from those of the Brucella species described thus far.
IMPORTANCE This report examines differences between genomes from four new Brucella strains and those from the classic Bru-
cella spp. Our results show that the four new strains are outliers with respect to the previously known Brucella strains and yet are
part of the genus, forming two new clades. The analysis revealed important information about the evolution and survival mecha-
nisms of Brucella species, helping reshape our knowledge of this important zoonotic pathogen. One discovery of special impor-
tance is that one of the strains, BO2, produces an O-antigen distinct from any that has been seen in any other Brucella isolates to
date.
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Brucellosis is a disease caused by Gram-negative bacteria in thegenus Brucella. This disease is zoonotic and endemic in many
areas throughout the world, causing chronic infections with com-
mon outcomes of abortion and sterility in infected animals. In
humans, it can cause a severe acute febrile state, producing focal
lesions in bones, joints, the genitourinary tract, and other organs.
The official classification of Brucella is based solely on phenotypic
characterization using a range of bacteriological, serological, and
biochemical tests (1, 56); classically, six nomenspecies (Bru-
cella abortus, B. canis, B. melitensis, B. neotomae, B. ovis, and
B. suis) have been described. Human infections, usually associated
with contact with infected animals and abortion materials or with
consumption of unpasteurized dairy products from infected ani-
mals (3, 4), are most often caused by B. abortus, B. melitensis, or
B. suis (5, 6).
The Brucella genus is expanding. Over the last 20 years, new
strains have been identified from marine mammals (7, 8), leading
to the designation of two new species (B. ceti and B. pinnipedialis).
Recently, strains showing atypical fast growth and the ability to
cause lethal infections in rodents (9) have been isolated from com-
mon voles (Microtus arvalis) and designated B. microti (10, 11).
This has led to the addition of at least three new branches to the
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traditional phylogeny of Brucella (10, 12–14). In the middle of the
first decade of the 21st century, two novel strains were isolated
from atypical human infections (15, 16). The first one described
was B. inopinata BO1T, isolated from an infected breast implant in
a 71-year-old patient from Oregon in the United States. BO1T is
very different from the classic species, showing very rapid growth
similar to that of B. microti. Although DNA-DNA hybridization
experiments and the presence of the Brucella-specific IS711 ele-
ment showed that the BO1T strain was a member of the Brucella
genus (15), BO1T has a unique biochemical profile and antimicro-
bial susceptibility, and 16S rRNA sequence and multilocus se-
quence typing (MLST) analysis shows that this strain is markedly
different from classic Brucella species (15). Thus, a new species,
B. inopinata sp. nov. type strain BO1T, was proposed (17). A sec-
ond unusual strain, BO2, was isolated from a 52-year-old Austra-
lian man with a history of chronic destructive pneumonia (16).
Standard biochemical profiles identified the strain as a member of
the Brucella genus, with the 16S rRNA sequence showing 100%
identity to that of BO1T (16). However, comparison of omp2a and
omp2b genes showed strong similarity between BO2 and the atyp-
ical B. suis strain 83-210 (16, 18).
A reexamination of seven strains isolated from native rat spe-
cies in Queensland, Australia, in 1964 (19, 20) and originally clas-
sified as B. suis biovar 3 (19, 20) has further changed the picture of
Brucella phylogeny. Both MLST and multiple-locus variable-
number tandem-repeat analyses have shown that these strains ex-
hibit distinct profiles, and phylogenetic analysis based on 16S
rRNA, recA, and rpoB genes demonstrated that these form a dis-
tinct clade separated from both the classic Brucella species and
BO2 (20). The primary hosts of the BO1T and BO2 strains are
unknown. Their similarity to two atypical Brucella strains isolated
from the Australian rodents suggested that they, too, might have a
rodent reservoir (16).
As BO1T and BO2 are unique and different from other Brucella
spp., they merit closer genomic scrutiny. We have performed
whole-genome sequencing of the genomes of B. inopinata strains
BO1T and BO2 and one representative of the rodent species,
NF2653. In this study, we present an analysis of these three ge-
nomes and compare them to other publicly available genomes in
the genus Brucella and to genomes of species of Ochrobactrum, a
genus that contains the closest known relatives of Brucella (21). As
the genome of rodent strain Brucella sp. 83-13 has been noted as
being particularly close to the genome of NF2653, its genome
sequence was also included in our detailed analysis. Based on these
results, and given the importance of lipopolysaccharide (LPS) in
Brucella virulence (22, 43), a biochemical analysis of the unique
LPS of BO2 was also carried out.
RESULTS AND DISCUSSION
General features of the genomes. Table 1 presents the general
features of the nearly complete BO1T, BO2, NF2653, and 83-13
genomes compared to the complete B. suis 1330 genome (23).
Values for the percentages of the genes annotated with functional
assignments or with hypothetical proteins or those assigned en-
zyme commission (EC) numbers are similar across all five ge-
nomes. Although none of the four new genome sequences is com-
plete, there is good evidence that, like all sequenced Brucella
strains, they have two chromosomes. All four genomes have the
oriC chromosomal replication initiation gene (24) on the large
chromosome. They also have the plasmid-like replication genes
repA, repB, and repC associated with the smaller chromosome
(23). In addition, sequence comparison to the genome sequence
of Brucella suis 1330 shows that contigs from all four genome
sequences map either to the main chromosome or to the second
chromosome (data not shown).
Phylogenetic analysis. A maximum-likelihood phylogenetic
analysis was performed based on 1,681 single-copy protein fami-
lies conserved over 17 Brucella and 5 closely related outgroup bac-
terial genomes that were used in this study (Table 2). The resulting
tree (Fig. 1A) shows that Ochrobactrum is the outgroup closest to
Brucella, as has been shown previously (25, 26). The Brucella re-
gion of this tree (Fig. 1B and 1C) basally branches into three
clades: a clade that contains 13 of the 17 Brucella nomenspecies
that we define as the classic clade; the N8 clade (containing
NF2653 and 83-13); and the BO clade (BO1T and BO2). There is
some uncertainty (83% bootstrap support) regarding the place-
ment of the N8 clade as a sister to the BO clade, rather than as a
TABLE 1 General features of the BO1T, BO2, NF2653, 83-13, and B. suis 1330 genomesa
Genome feature
Value for indicated genome
B. inopinata Brucella sp. B. suis
BO1 BO2 NF2653 83-13 1330
Size (bp) 3,366,774 3,305,941 3,110,281 3,153,851 3,315,175
No. of contigs 55 174 113 20 2
%GC 57 56.8 57 56.5 57.2
Sequencing coverage 17.4 25.7 29.1 28.5 Complete
Protein-coding genes
Total 3,404 3,350 3,250 3,167 3,432
No. (%) with functional assignment 2,624 (77.0) 2,583 (77.1) 2,522 (77.6) 2,508 (79.1) 2,699 (78.6)
No. (%) hypothetical 780 (22.1) 767 (22.8) 728 (22.4) 659 (20.8) 733 (21.3)
No. (%) of proteins with EC no. 886 (26.0) 875 (26.1) 869 (26.7) 823 (25.9) 884 (25.7)
RNA
No. of rRNA operons 3 3 3 3 3
No. of tRNAs 49 49 49 49 55
a For the first four strains, the numbers are totals for the presumed two chromosomes. B. suis 1330 is included as a reference. Sequence assembly identified only one rrn operon, as
the sequences are identical. However, Southern blotting and digestion with I-CeuI confirmed the presence of 3 rrn operons (G. Bourg, B. Saadeh, and D. O’Callaghan, unpublished
data).
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sister to the classic clade, but both the N8 and BO clades are con-
sidered early-diverging relatives of the classic clade.
Regions specific to the classic Brucella species are missing in
new Brucella strains. We have identified 20 genomic regions that
are present in the classic Brucella genomes and absent in BO1T,
BO2, NF2653, and 83-13 (Table 3). A complete list of the missing
genes found in these regions is provided (see Table S1 in the sup-
plemental material). Genes identified in region 1 were based on
B. abortus 2308, as the genes that it contains are missing from
B. suis 1330. Genes from all other regions were based on the B. suis
1330 genome. The regions specific to the classic Brucella species
range in size from the smallest (region 3, at 706 nucleotides [nt])
to the largest (region 20, at 47,259 nt). The proportion of hypo-
thetical genes annotated in these regions is 42%, with the average
across the entire B. suis 1330 genome being 21% (Table 1).
Both strains 83-13 and NF2653 are missing regions present in
the classic and BO clades. Combined, these sections total more
than 146.4 kb, corresponding to 152 genes, with 34.8 kb missing
from what is the first chromosome in B. suis 1330 and 108.3 kb
from the second (see Table S2 in the supplemental material).
Some of the genes in these regions that are missing in the N8 clade
have been annotated with specific functionality. Among these is
region 10, a 26.9-kb section of B. suis 1330 containing five syntenic
genes that are involved in tyrosine metabolism. In Escherichia coli,
these genes are defined as part of the hpc operon, a meta-cleavage
pathway involved in the degradation of homoprotocatechuate
(3,4-dihydroxyphenlacetate), an aromatic compound used as a
source of carbon or nitrogen (27). All other Brucella genomes
maintain this capability, while strains 83-13 and NF2653 appar-
ently function without it.
The genomes in the BO clade are also uniquely missing regions
that are conserved among the other Brucella strains (see Table S3
in the supplemental material). Many of the genes in the Wbk
region (region 2; see Table S3 in the supplemental material), con-
taining several of the genes important in LPS synthesis and main-
tained by BO1T, have been lost from BO2. In BO2, this region
carries the unique genes encoding dTDP-4-dehydrorhamnose re-
ductase (rmlD), dTDP-glucose 4,6-dehydratase (rmlB), dTDP-4-
dehydrorhamnose 3,5-epimerase (rmlC), and glucose-1-
phosphate thymidylyltransferase (rmlA). These four genes are
involved in the formation of the O-antigen component of the LPS
in many Gram-negative bacteria (28) but were not previously
known to be present in Brucella and are discussed in more detail
below.
New Brucella strains have unique regions not found in the
classic Brucella genomes. The four new strains had unique re-
gions in their genomes that are not present in the classic Brucella
species (Table 4). None of these are shared between the N8 and BO
clades but are specific to each clade. Details of each of these re-
gions, including the size, the number of genes, and their locations
on contigs, are available in Table S4 in the supplemental material.
(i) Shared regions: BO1T and BO2. The BO1T and BO2 ge-
nomes had 11 regions they share that are not present in the other
Brucella genomes. They ranged in size from 4.7 to 74.6 kb (Ta-
ble 4). These unique regions had a significantly higher number of
hypothetical proteins, with 56% in BO1T and 47% in BO2 (Ta-
ble 4), than is seen across the genome at large (22% or 23%; Ta-
ble 1), and several had flanking tRNA genes, a hallmark of mobile
genomic islands.
Of particular interest is region B-7 (10.8 kb), which had a num-
ber of genes coding for proteins associated with L-rhamnose uti-
lization. These genes included an isomerase, an aldolase, a tran-
scriptional regulator, and proteins associated with an ABC
transporter (see Table S4 in the supplemental material), which
were all conserved in both strains in this clade. This region was
present in both Ochrobactrum genomes as well as in the genomes
of several Agrobacterium and Rhizobium species (occurring there
in secondary chromosomes or in large plasmids).
TABLE 2 Genomes used in analysisa
Species Strain No. of contigs Accession no. Size (nt)
Brucella abortus S19 2 NC_010742, NC_010740 3,283,936
Brucella abortus 2308 2 NC_007618, NC_007624 3,278,307
Brucella abortus 2308A 9 NZ_ACOR01000001-NZ_ACOR01000009 3,277,197
Brucella abortus 9-941 2 NC_006933, NC_006932 3,286,445
Brucella melitensis 16 M 2 NC_003317, NC_003318 3,294,931
Brucella melitensis ATCC 23457 2 NC_012441, NC_012442 3,311,219
Brucella ovis ATCC 25840 2 NC_009504, NC_009505 3,275,590
Brucella ceti Cudo 7 NZ_ACJD01000001-NZ_ACJD01000007 3,389,269
Brucella neotomae 5K33 11 NZ_EQ999575-NZ_EQ999585 3,329,623
Brucella canis ATCC 23365 2 NC_010104, NC_010103 3,312,769
Brucella suis 1330 2 NC_004310, NC_004311 3,315,175
Brucella suis ATCC 23445 2 NC_010169, NC_010167 3,324,607
Brucella microti CCM 4915 2 NC_013119, NC_013118 3,337,369
Brucella sp. 83-13 20 NZ_DS999649-NZ_DS999668 3,153,851
Brucella sp. NF2653 113 ADFB01000000 3,106,792
Brucella inopinata BO1 55 ADEZ00000000 3,366,774
Brucella inopinata BO2 174 ADFA00000000 3,305,941
Ochrobactrum anthropi ATCC 49188 6 NC_009667, NC_009668, NC_009669, NC_009670,
NC_009671, NC_009672
5,114,435
Ochrobactrum intermedium LMG 3301 4 NZ_ACQA00000000 4,725,392
Bartonella quintana Toulouse 1 NC005955 1,581,384
Mesorhizobium loti MAFF303099 3 NC_002678, NC_002679, NC_002682 7,596,297
Agrobacterium tumefaciens C58 5 NC003064, NC003065, NC003062, NC003063, NC004972 5,682,546
a Accession numbers of unclosed genomes are abbreviated to the first and last of the sequential numbers to save space where applicable.
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BLASTN analysis of region B-9 (9.2 kb) shows a good match
(94% coverage, 72% nt identity) to a region in plasmid pRLG201
of Rhizobium leguminosarum bv. trifolii WSM2304; parts of this
region also appear (total coverage, between 43% and 50%, with
66% nucleotide identity in the largest matched section) in the
genomes of several Burkholderia species. Further investigation of
this region showed that it was part of a larger match (27.9 kb)
between pRLG201 and contig NZ_ADEZ01000028 in BO1T
(22.6 kb of this region was also present in the BO2 genome but on
three separate contigs). A BLASTN analysis of GenBank’s NR da-
tabase using the extended BO1T region as the query showed that
the genomes of several other Brucella species had good matches to
the first part of this region (see Fig. S1 in the supplemental mate-
rial); the section corresponding to B-9 was clearly absent from the
alignment. These results and the phylogenetic relationship be-
tween Brucella and Rhizobium suggested that the extended
matched region in the R. leguminosarum and BO1T genome se-
quences represents the ancestral condition and that region B-9
was lost by the other sequenced Brucella genomes as well as by all
other sequenced members of the Rhizobiales order. While not par-
ticularly parsimonious, this explanation seems to fit better with
the absence of any horizontal gene transfer evidence. The protein-
coding gene content of the extended region is shown in Table S5 in
the supplemental material.
Region B-5 (74.6 kb in BO1T and 35.7 kb in BO2) is another
region not seen in either Ochrobactrum genome. It had many
phage and hypothetical genes, but there was no large-scale simi-
larity to regions in other completed or draft genomes available
from GenBank.
(ii) Shared regions: 83-13 and NF2653. There were eight re-
gions in strains 83-13 and NF2653 that none of the other Brucella
genomes share (Table 4). Few genes in these areas had functional
FIG 1 Maximum-likelihood tree for 17 Brucella and 5 outgroup species. All nodes received 100% bootstrap support except for the three that are otherwise
marked. (A) Full tree. (B) Brucella region only. (C) Brucella region in cladogram form.
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assignments, the vast majority (80% in 83-13 and 82% in NF2653)
of the genes being annotated as hypothetical. This differs from
what is seen more broadly across these genomes, where the ma-
jority of the genes have been annotated with functional assign-
ments (Table 1).
(iii) Unique regions. The BO1T genome had five unique re-
gions that total 39.7 kb (Table 4), and most of the genes associated
with these regions were annotated as hypothetical (69%). Specific
genes and their locations are provided (see Table S4 in the supple-
mental material).
BO2 also had five unique regions, totaling 52.4 kb (Table 4),
with many of the genes annotated as hypothetical (48%). One of
these regions (BO2-2) was unique in having a number of genes
involved in rhamnose-based LPS O-antigen synthesis (see Table
S4 in the supplemental material).
LPS synthesis genes. Nineteen genes essential to the synthesis
of LPS and necessary to produce the smooth phenotype have been
identified in B. melitensis (29, 30). The presence or absence of all
known LPS genes in the four new genomes is shown in Table 5. As
these genomes are not closed, it is difficult to make absolute state-
ments about specific genes that appeared to be missing, and a
BLASTN search of the genome was carried out for genes not an-
notated in any of the four new genomes. There are several differ-
ences found in the new genomes compared to those of smooth
members of the classic Brucella clade. The wbkD gene in the
NF2653 strain has a single nucleotide deletion that results in a
frameshift that truncates the gene. As NF2653 is smooth and mu-
tation of wbkD has been shown to result in a rough phenotype
(30), which is present in the classic rough Brucella species (26, 31),
we believe that the deletion is a sequencing error. There are two
copies of the manB gene in the classic Brucella genomes: manBcore
(BRA0348 in 1330) is thought to play a role in synthesis of the LPS
core, and manBO-Ag is part of the Wbk region (BR0537 in 1330),
but its role in O-antigen synthesis is unclear. While all four new
genomes have copies of manBcore, no gene is annotated as
manBO-Ag in the genome of either 83-13 or NF2653. BLASTN
searches show that manBO-Ag in both 83-13 and NF2653 is missing
837 of 1,404 nt compared to its homolog (BR0537) in B. suis 1330;
what remains of the gene has many deletions. NF2653 and 83-13
also share a conserved insertion, resulting in a frameshift muta-
tion that extends the normally 284-nt wbkB gene to 575 nt. Early
evidence indicated that ManBO-Ag was necessary for converting
mannose-6-phosphate to mannose-1-phosphate (32), but muta-
tion of this gene in B. melitensis 16M did not produce a rough
phenotype (30). As the manBO-Ag gene in all known B. ceti strains
is truncated by a naturally occurring transposon and yet these
strains are smooth (26, 31), this could be considered further evi-
dence that ManBO-Ag is not required for LPS synthesis.
The Wbk region in strains NF2653 and 83-13 has a few differ-
ences with respect to the other Brucella strains. Whereas, in all
other Brucella strains, the wbkB gene has 855 nt, in NF2653 and
83-13 the gene is twice as long (1,728 nt). Mutations in this gene in
other Brucella strains have not resulted in an altered LPS (29),
making it seem unlikely that this mutated version has any impact
on LPS synthesis. There is also a hypothetical protein annotated
between wbkC and wbkB (Fig. 2) that has strong similarity (e-
value, 1063) to wboA, making this a potential paralog. The pres-
ence of this second wboA-type gene in the members of the N8
clade prompted a closer look at that gene and its neighbor wboB.
The wboA and wboB genes from the classic Brucella strains have
almost 100% identity (by BLASTN) to each other, but those from
83-13 and NF2653 have considerably reduced percentages of
identity (82% for wboA and 80% for wboB), indicating that they
either have diverged significantly or had different origins.
BO2 produces an atypical smooth LPS. The BO1T genome
appears to carry the full complement of LPS genes seen in the
classic Brucella (Table 5). Although gene wbkA is not present in the
BO1T annotation, BLASTN shows that most of this gene (1,110 of
1,119 total nucleotides) is present, and its sequence runs to the end
of contig NZ_ADEZ01000023. Presumably, the remaining 9 nt are
TABLE 3 Summary of regions present in the genomes of the classic Brucella clade and missing in strains BO1T, BO2, NF2653, and 83-13a
Chromosome Region Size (nt)
No. (%) of genes
Presence of tRNATotal Hypothetical Named
1 1 21,256 29 23 6
2 4,270 7 2 5 
3 706 3 2 1
4 16,174 16 9 7 
5 2,012 4 4 0 
6 7,242 16 10 6
7 1,378 5 3 2
8 6,489 9 7 2 
9 2,800 6 4 2
10 5,140 6 3 3 
11 2,069 5 1 4
12 9,203 12 2 10 
2 13 1,193 3 3 0
14 5,923 7 2 5
15 17,696 17 10 7
16 10,704 11 1 10
17 16,645 19 3 16 
18 7,384 8 0 8
19 3,764 6 6 0 
20 47,259 46 3 43 
Total 189,307 235 98 (42) 137 (59)
a Regions 1 and 2 are from B. abortus 2308, and all others are from B. suis 1330.
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TABLE 4 Summary of the size, number, and presence or absence of tRNA-associated genes across regions unique or
shared in the four Brucella strain genomes studied herea
a For the regions shared by strains NF2653 and 83-13, each of the areas is identified by the prefix N8 (N for NF2653 and 8 for 83-13) followed by
the number of the region. For the regions shared by strains BO1T and BO2, each of the areas is identified by the prefix B.
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present in the genome and this gene is functional in BO1T. Anal-
ysis of the BO2 genome shows that 13 LPS genes are not present in
the annotation and cannot be found by BLASTN (Table 5). The
wboA and wboB genes, not present in BO2, have been discussed
above. The other missing genes (wbkC, wbkB, wzt, wzm, per, gmd,
wbkA, manB, manC, manA, and wbkE) are in the Wbk region,
leaving only wbkD and wbkF still present. This should mean that
BO2 is unable to make the N-formyl-perosamine-based
O-antigen found in the classic smooth Brucella strains. This would
explain why it does not agglutinate with the classic A-and
M-specific antisera used to type Brucella strains and why it is not
sensitive to the classic Brucella phage (16).
As BO2 appears to be missing most of the genes that the other
Brucella strains require to produce O-antigen, it is possible that,
like B. ovis and B. canis, BO2 is naturally rough. However, the
absence of autoagglutination in acriflavine (data not shown) ar-
gues against this. Interestingly, the BO2 Wbk region carries four
unique genes not seen in any other Brucella strains: rmlA, rmlB,
rmlC, and rmlD (Fig. 2 and Table 5; see also Table S4 in the sup-
plemental material). These four genes also exist in an operon in
other bacteria (28) and catalyze the conversion of glucose-1-
phosphate to dTDP-l-rhamnose (33). Rhamnose is an important
residue in the O-antigen in many Gram-negative bacteria, and
dTDP-l-rhamnose is an immediate precursor of the rhamnose
moiety in the O-antigen (34). Both Ochrobactrum genomes also
contain these four genes in an operon associated with other LPS
genes (data not shown). Further evidence that this operon is active
in LPS synthesis is the presence of rhamnitol and glucosamitol as
the main sugar components of the O-antigen of O. anthropi (35).
This suggests that BO2 uses these genes to produce a novel O-side
chain. As noted above, both BO1T and BO2 carry genes not found
in other Brucella strains that encode enzymes involved in rham-
nose uptake and metabolism. In addition, the absence of wzm and
wzt is significant, since they encode the ABC transporters involved
in the export of all known homopolymeric O-antigens (36), in-
cluding that of the classic smooth Brucella species. Also significant
is the conservation of wbkD and wbkF: they encode proteins pu-
tatively related to bactoprenol priming for O-antigen polymeriza-
tion, a function essential in the generation of smooth-type LPS. All
of these genetic features are consistent with the presence of a
smooth LPS in BO2 carrying a heteropolymeric, possibly
rhamnose-based, O-antigen. Concerning the LPS core oligosac-
charide, the gene encoding the 2-keto-3-deoxy-D-manno-
octulosonic acid (Kdo) transferase (waaA) was present as ex-
pected from the constant presence of this sugar in all Gram-
negative LPSs. In the classic Brucella species, three additional
glycosyltransferase genes, wadA (previously called wa**), wadB,
and wadC (22, 37, 38), have been identified thus far, and homo-
logues of these three genes were identified in all the newly se-
quenced genomes. This finding is in keeping with the fact that core
oligosaccharide genes are usually conserved among closely related
bacteria, but does not necessarily mean a total structural identity
at the core level with the classic Brucella spp. In fact, Zygmunt et al.
(39) have recently reported that sodium dodecyl sulfate (SDS)-
proteinase K-extracted LPSs of BO1T and BO2 fail to react with a
monoclonal antibody specific for the lipid A-core region of the
classic Brucella species, suggesting there exist some differences in
this region of the molecule.
To confirm that BO2 synthesizes a smooth LPS, we isolated
LPSs from strains 2308, BO1T, and BO2 and examined them by
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and silver
staining (Fig. 3). As expected, 2308 and BO1T LPS were present
only in the phenol phase (lanes A and B, respectively) and not the
aqueous phase (lanes D and C, respectively) following hot aque-
ous phenol extraction. In contrast, the O-antigen of BO2 dis-
played the discontinuous ladder-like pattern typical of those LPSs,
with O-antigens made of repeated oligosaccharide units (2). In-
terestingly, the BO2 LPS partitioned almost equally into the water
(lane E) and phenol (lane F) phases. The only minor difference
was that the phenol-phase LPS was more enriched in small-
molecule-size components. This partition pattern is consistent
with both the absence of N-formyl-perosamine (phenol solubility
is a trait of N-formyl) or N-acetyl-perosamine O-antigens (40, 41)
and the highly hydrophobic structure of Brucella lipid A (38). The
monoclonal antibody Bru-38, recognizing the N-formyl-
perosamine O-antigen, reacted with B. abortus 2308 and S19 LPSs
(both A-dominant O-antigens) but did not react with either the
aqueous-phase or the phenol-phase LPS from BO2 by immuno-
blotting. However, BO1T LPS (from the phenol phase only) also
reacted with Bru-38 (data not shown). These results are consistent
with those recently reported by Zygmunt et al. (39), who found
that BO1T, although reacting weakly with a polyclonal M-specific
antiserum used in routine typing, was recognized by some
M-specific monoclonal antibodies. However, BO1T has an anom-
alously high reactivity with a monoclonal antibody of C/Y (A 
M) specificity, which is in agreement with reactivity to antibody
Bru-38. Moreover, those same authors also reported that BO2 LPS
is smooth but not reactive to monoclonal antibodies to either A or
M epitopes. Compositional analysis of the BO2 LPS by gas
chromatography-mass spectrometry (GC-MS) confirmed that,
unlike LPS from the classic Brucella spp., rhamnose, as well as
galactose, is a major component of the carbohydrate region
(Fig. 4A). Glucose, glucosamine, and Kdo are also present and are
components of the core region of classic Brucella LPS (32). Of
interest was that only a small amount of mannose, which is a
component of the core oligosaccharide of most smooth Brucella
TABLE 5 Summary of presence, absence, or alteration of sequence of genes involved in LPS synthesis in Brucellaa
Strain
Presence, absence, or alteration of sequence of indicated gene
wbkD wbkF wbkC wbkB wzt wzm per gmd wbkA manB manC manA wbkE wboA wboB wadA wadB wadC waaA pgm manB core manC core rmlD rmlB rmlC rmlA
Smooth
Brucella
                      O O O O
83-13    #      #             O O O O
NF2653 #   #      #             O O O O
BO1T                       O O O O
BO2   O O O O O O O O O O O O O           
a , presence; O, absence; #, alteration of sequence. Data are partly based on identifications by González et al. (30), as visualized among the smooth Brucella members, the known
rough species, and the four new strains.
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strains, was detected in BO2 LPS (Fig. 4A [the small peak to the left
of the galactose peak]). This result is consistent with the small
amount of mannose observed in rough Brucella LPS (42). A pos-
sible explanation is that the mannose is phosphorylated or bears
an acid-resistant residue, which would make it not subject to
cleavage by methanolysis. In addition, 2,6-dideoxy-2-amino-
hexose, which occurs in classic Brucella LPS as quinovosamine,
was present (37). A variety of fatty acids, including C14:0, C15:0,
C14:03-OH, C16:03-OH, C17:03-OH, C18:03-OH, and some
C28:027-OH, were identified in BO2 LPS. If confirmed, the C15:0
and C17:03-OH fatty acids would be considered novel in Brucella
LPS.
Experimental and bioinformatic evidence indicates that strain
BO2 synthesizes a polysaccharide containing the sugars rhamnose
and galactose, which are distinct from the glycoses present in other
Brucella isolates. Furthermore, the genes in the rml operon, to-
gether with wbkD and wbkF (see above), appear to form an
O-antigen that is united with the core oligosaccharide. It is un-
known how BO2 transports its O-antigen to the periplasmic side
of the cell where it would be ligated to the lipid A core (38). The
wzm/wzt ABC transporter genes are missing in BO2, but their
presence would be in conflict with the observed ladder-like pat-
tern, because, as noted above, these ABC transporters are involved
only in the export of homopolymeric O-antigens. O-antigens
made of repeating oligosaccharide units are synthesized through
the so-called wzy-dependent pathway, but no clear wzy homo-
logue could be identified in the BO2 genome. A search for the
genes involved would require the construction of rough mutants.
However, to date BO2 has been recalcitrant to all attempts at ge-
netic manipulation (B. Saadeh and D. O’Callaghan, unpublished
data).
Since LPS is a critical virulence factor of Brucella (43), the pres-
ence of an alternative O-polysaccharide structure is striking. The
typical N-formyl-perosamine O-polysaccharide of the three clas-
sic smooth Brucella species is known to contribute to resistance to
complement-mediated killing and bactericidal peptides. More-
over, evidence obtained with B. suis strongly suggests that the
N-formyl-perosamine O-polysaccharide also plays a role in the
interaction with lipid rafts of the cell membrane, permitting
the bacterium to enter cells through a pathway that makes it
possible to reach the replicative intracellular niche (44). Al-
though further research is necessary, it seems that the alterna-
tive O-polysaccharide structure present in BO2 can perform at
least some of these roles. This hypothesis is in keeping with
previous interpretations that the Brucella O-polysaccharide
sterically protects outer membrane targets from complement
and bactericidal peptides and that it also prevents the unspe-
cific binding to cells manifested by rough mutants, thereby
allowing effective selection of the port of entry (30). The
finding of a virulent Brucella strain with an alternative
O-polysaccharide supports the interpretation that, in spite of a
different chemical composition, the O-antigen allows the spe-
cies to retain its ability to infect and cause disease.
In conclusion, the analysis of the draft genomes of the four new
FIG 2 Comparison of the wbk regions across Brucella strains, with orientation based on B. suis 1330. Flanking genes are noted outside the dashed boxes, which
represent the wbk regions. The contigs on which the genes occur are noted.
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strains demonstrates clearly that they are true Brucella species. It
also shows that the genus is far more diverse than previously imag-
ined and suggests that many Brucella strains do not fit into the
phenotypic definitions drawn up in the 1970s based on the classic
Brucella strains (45).
MATERIALS AND METHODS
Genome sequencing and annotation. Genomes of the three newly iden-
tified strains, B. inopinata type strain BO1T, B. inopinata-like strain BO2,
and Brucella spp. NF2653, were sequenced using Roche 454 technology to
draft status (coverage values are given in Table 1) and assembled by the
Centers for Disease Control and Prevention (CDC). Genomes were an-
notated by the PAThosystems Resource Integration Center (PATRIC;
http://www.patricbrc.org) using the RAST pipeline (46). The gene anno-
tations for the 3 newly sequenced genomes and 14 additional Brucella
genomes were acquired from PATRIC (57, 58), where they were anno-
tated consistently using RAST (46). All genome sequences and annota-
tions described here are available at PATRIC (http://www.patricbrc.org).
Details about the annotation statistics of these newly sequenced genomes
are given in Table 1, and a complete list of the genomes from Brucella and
those from species used as outgroups that were used in this study is given
in Table 2.
OGs and synteny analysis. OrthoMCL (59) was used to create groups
of orthologous proteins. To create a representative set of ortholog groups
(OGs) for the Brucella strains and their closest relatives, genomes from
Ochrobactrum anthropi, O. intermedium, Bartonella quintana, Mesorhizo-
bium loti, and Agrobacterium tumefaciens were included (Table 2). The
new Brucella genomes are not closed and are in multiple contigs, compli-
cating traditional analyses that look for genomic specificities. Syntenic
strings of singleton or low-membership OGs were recognized by consec-
utive locus tags and verified by manual inspection of the genome. Follow-
ing identification of syntenic areas of interest, the nucleotide sequence for
the entire region was used in a BLASTN search (47) of all Brucella ge-
nomes in PATRIC. Regions that had lacked BLAST hits in specific ge-
nomes, or across large groups of genomes, were noted as especially inter-
esting. These areas were also checked to see if they were associated with
tRNA genes, as these are a hallmark of genomic islands.
Phylogenetic analysis. Of all the protein families for the Brucella and
outgroup genomes, 1,681 were found to have one and only one represen-
tative in each Brucella genome and these were used for the phylogenetic
analysis. Each of these families was made representative of the outgroup
strains by excluding strains with two or more members in the family,
leaving O. anthropi represented in 1,564 families, O. intermedium in 1,527,
B. quintana in 730, M. loti in 1,360, and A. tumefaciens in 1,352. The
protein sequences of each family were aligned using MUSCLE (60), and
ambiguous portions of the alignment were removed using Gblocks (48).
The concatenation of these alignments contained 494,836 amino acid
characters. RAxML 7.2.3 (49) was used with the PROTGAMMALG model
to prepare a maximum-likelihood tree and in its quick mode to prepare
100 bootstrap trees.
Unique regions. Regions found in any of the four new genomes and
not found in the classic Brucella genomes by BLASTN (47) were identified
as being “unique.” These unique syntenic protein signatures were ex-
panded in both the 5= and 3= directions along the specific contigs to find
the endpoints where conservation with the other Brucella genomes con-
tinued and genes that were broadly shared across Brucella strains began.
LPS purification and analysis. The LPS was extracted as previously
described (42, 50) with minor modification. Briefly, acetone-dried cells
FIG 3 Electrophoretic profiles of the LPS produced by B. abortus 2308 and
B. inopinata-like strains BO1 and BO2. Lanes: A, B. abortus 2308 LPS isolated
from the phenol phase; B, BO1 LPS isolated from the phenol phase; C, BO1
LPS isolated from the aqueous phase; D, 2308 LPS isolated from the aqueous
phase; E, strain BO2 LPS isolated from the aqueous phase; F, BO2 LPS isolated
from the phenol phase.
FIG 4 GC-MS (gas chromatography-mass spectrometry) analysis of glycoses
and fatty acids in the LPS of Brucella BO2. (A) Acetylated O-methyl glycoside
(MGA) profiles. Rhamnose and galactose are unique glycose components of
the BO2 LPS. (B) Fatty acid methyl esters (FAME) of BO2 LPS. C17:03-OH
and C15:0 have not been described in other Brucella LPSs. Abbreviations used:
Rha, rhamnose; 6 d-Hex2N, 2-amino-2,6-dideoxy-hexose; Man, mannose;
Gal, galactose; Glc, glucose; GlcN, glucosamine; Kdo, 2-keto-3-deoxy-D-
manno-octulosonic acid; UNK, unknown component. HexN* should repre-
sent a minor peak derived from GlcN.
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were suspended in 50 ml of sterile, distilled water, an equal volume of 45%
phenol was added, and the mixture was stirred at 65 to 70°C for 15 min.
The sample was then cooled to 15°C, diluted with distilled water, and
dialyzed under running tap water until no phenol odor remained (about
2 days). The solid brown, proteinaceous precipitate was discarded, and the
soluble and white insoluble material was subjected to centrifugation at
3,000  g at 15°C. Sodium acetate (30 mM final concentration) was added
to the supernatant, three volumes of cold 95% ethanol was added, and the
mixture was held at 20°C for 2 h. The sample was centrifuged at 10,000
 g for 30 min at 4°C. The pellets from the initial centrifugation and from
the ethanol precipitation were suspended in 50 mM sodium phosphate
buffer containing 20 mM MgCl2 and 5 mM EDTA (pH 7.0). DNase (Qia-
gen RNase-Free DNase Set; Qiagen, Valencia, CA) and RNase (riboshred-
der RNase blend; Epicenter, Madison, WI) were sequentially added to
achieve a final concentration of 2 g/ml, and the mixtures were incubated
at 37°C for 1 h each. The temperature was then raised to 60°C, proteinase
K (Sigma-Aldrich, St. Louis, MO) was added to achieve a final concentra-
tion of 20 g/ml, and the mixtures were incubated overnight. The extrac-
tion with phenol was repeated as described above, but the phenol and
aqueous phases were separated by centrifugation. The aqueous phase was
removed, and the phenol phase and interface were passed through What-
man grade 40 filter paper. Three volumes of cold (20°C) methanol re-
agent (1 part methanol saturated with sodium acetate to 99 parts metha-
nol) was added to the aqueous and clarified phenol phases and incubated
overnight at 20°C. The samples were subjected to centrifugation at
10,000  g for 30 min at 4°C, and the pellets were suspended in distilled
water and lyophilized. LPS samples (20 g) were analyzed by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and
stained with ammoniacal silver, as previously described (51, 52). Some
samples were further analyzed by immunoblotting (53), using a 1:100
dilution of Bru-38 monoclonal antibody to B. abortus LPS (54).
Fatty acid and monosaccharide composition was obtained by treating
LPS (about 1 mg) with methanolic HCl (1 ml) at 80°C for 18 h. The
solution was extracted twice with equal volumes of n-hexane, the two top
layers (n-hexane) were combined and dried, and the fatty acid methyl
esters were analyzed directly by GC-MS. The bottom layer (methanol) was
dried with a stream of air and the resulting methyl glycosides were acety-
lated as reported elsewhere (55). All GC-MS analyses were performed on
a Hewlett-Packard 5890 instrument equipped with an SPB-5 capillary
column (Supelco) (30 m by 0.25 inner diameter [i.d.]; flow rate, 0.8 ml/
min; He as carrier gas), with the following temperature program: 150°C
for 3 min, a gradient of 150 to 300°C with increases at 10°C/min, and
300°C for 18 min. Electron impact mass spectra were recorded with an
ionization energy of 70 eV and an ionizing current of 0.2 mA.
Nucleotide sequence accession numbers. The whole-genome shot-
gun project and the annotations for B. inopinata strain BO1T have been
deposited under accession no. ADEZ00000000 at DDBJ/EMBL/GenBank,
and the version described in this paper is the first version, ADEZ01000000.
Similarly, for the other strains, the deposit accession number and the acces-
sion number of the version described in this paper, respectively, are as follows:
for BO2, ADFA00000000 and ADFA01000000; and for NF2653,
ADFB00000000 and ADFB01000000. The genome of strain 83-13 was se-
quenced by the Broad Institute and is available from GenBank under acces-
sion number ACBQ00000000.
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